Trials / Conditions / BRCA1/2 Mutation
BRCA1/2 Mutation
4 registered clinical trials studyying BRCA1/2 Mutation — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer NCT06783140 | University Health Network, Toronto | Phase 2 / Phase 3 |
| Completed | Long-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations NCT06429644 | Hanyang University Seoul Hospital | — |
| Unknown | Bilateral Prophylactic Mastectomy; Should we Preserve the Pectoral Fascia? NCT05391763 | Erasmus Medical Center | N/A |
| Active Not Recruiting | INO 5401 Vaccination in BRCA1/2 Mutation Carriers NCT04367675 | Abramson Cancer Center at Penn Medicine | Phase 1 |